Labcorp Reaffirms 2029 Outlook Despite CMS Lab Rate Cuts
LH sits 27% above its 52-week low of $244.52 on elevated volume (2.6× avg).
Summary
Labcorp reaffirmed its 2026-2029 long-term outlook after CMS released preliminary lab fee schedule rates, saying the cuts are already reflected in its targets and it will quantify the 2027 impact in February.
Key Events · Earnings and Guidance · LH
-
Long-Term Outlook Reaffirmed
Labcorp reaffirmed its 2026-2029 targets: 5-8% revenue CAGR, 8.5-11.5% adjusted EPS CAGR, 75-150 bps adjusted operating margin expansion, and FCF growth in line with adjusted earnings.
-
CMS Rate Cut Response
CMS released preliminary 2027-2029 Clinical Laboratory Fee Schedule rates on September 21, 2026; Labcorp says the rates are based on unrepresentative data and would impose steep annual payment cuts.
-
2027 Guidance Timing
Labcorp will provide additional information on the impact of CMS payment rates on its 2027 financial guidance when that guidance is announced in February 2027.
-
Legislative Advocacy
Labcorp continues to support the bipartisan RESULTS Act as a solution to ensure a sustainable laboratory system.
Analysis · LH · Industrial Applications And Services
Labcorp is formally reaffirming its 2026-2029 long-term targets — 5-8% revenue CAGR, 8.5-11.5% adjusted EPS CAGR, and 75-150 bps of adjusted operating margin expansion — in direct response to CMS's preliminary 2027-2029 Clinical Laboratory Fee Schedule rates released September 21. The company argues the rates are based on unrepresentative data and would impose steep annual cuts, and it continues to back the bipartisan RESULTS Act. The reaffirmation matters because it signals management believes the reimbursement pressure is already baked into its long-term plan, but the company is deferring any 2027 guidance impact until February 2027, leaving near-term uncertainty unresolved.
How filings like this one have moved
In the 30 days to Oct 15, 2026, 29% of the 1483 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.47%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, LH was trading at $311.54 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $25.3B. The 52-week trading range was $244.52 to $341.80. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.